APA (7th ed.) Citation

K, D., M, B., K, G., J, K., A, S., U, D., . . . LE, R. (2024). Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use. Journal of clinical pharmacology, 64(10), 1295. https://doi.org/10.1002/jcph.2462

Chicago Style (17th ed.) Citation

K, Dao, et al. "Novel Patient-Friendly Orodispersible Formulation of Ivermectin Is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use." Journal of Clinical Pharmacology 64, no. 10 (2024): 1295. https://doi.org/10.1002/jcph.2462.

MLA (9th ed.) Citation

K, Dao, et al. "Novel Patient-Friendly Orodispersible Formulation of Ivermectin Is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use." Journal of Clinical Pharmacology, vol. 64, no. 10, 2024, p. 1295, https://doi.org/10.1002/jcph.2462.